November 07, 2025

3 things you missed in government this week

ADA News is providing a roundup of government happenings you may have missed this week.

ADA News

November 06, 2025

‘Wasteful’? Doctors Call It Essential

Proposed cuts to the Hospital Preparedness Program may limit hospitals’ capacity to manage pandemics, natural disasters, and mass-casualty events affecting U.S. health systems.

KFF Health News

November 06, 2025

Lumateperone Approved for Major Depression

The atypical antipsychotic demonstrated statistically significant improvements over placebo in two phase 3 trials, with separation from placebo emerging within 1 to 2 weeks and 65% of patients achieving remission at 6 months.

Conexiant

November 05, 2025

FDA Approves First Pediatric IBS-C Treatment

Linzess becomes the first treatment cleared for pediatric irritable bowel syndrome with constipation.

Conexiant

November 05, 2025

George Tidmarsh: FDA Resignation and Lawsuit

Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit

The Medicine Maker

October 31, 2025

Single-Injection Omvoh Option Simplifies Ulcerative Colitis Care

The FDA approved Eli Lilly’s interleukin-23p19 antagonist Omvoh (mirikizumab-mrkz) as a once-monthly single-injection maintenance option for adults with moderately to severely active ulcerative colitis.

Conexiant

October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 28, 2025

Insurance Shake-Up: Who Loses Out?

Families nationwide face rising health insurance costs as Affordable Care Act subsidies near expiration, with premiums and deductibles projected to increase amid congressional inaction.

KFF Health News